Workshop on biosimilars

EventCorporateBiosimilars

Italian is available via eTranslation, the European Commission's machine translation service.

Translate to Italian | Important information about machine translation

Data

Giovedì, 31 Ottobre 2013, All day

Posizione

European Medicines Agency, Amsterdam, the Netherlands

The workshop is intended to discuss the draft guideline on similar biological medical products, the draft guideline on similar biological medical products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues, and the draft guideline on similar biological medical products containing biotechnology-derived proteins as active substance: quality issues. Registration closed.

Documents

Agenda - Workshop on biosimilars

Reference Number: EMA/473908/2013

English (EN) (74.69 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

List of participants - Workshop on biosimilars

Reference Number: EMA/681299/2013

English (EN) (143.9 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - Draft revised guideline on similar biological medicinal products: Relevant changes (Martina Weise)

English (EN) (234.06 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - EBG’s comments on the draft revised guideline on similar biological medicinal products (Karl Heinz Emmert)

English (EN) (1.09 MB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - Guideline on similar biological medicinal products: Overarching guideline

English (EN) (734.59 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - Guideline on similar biological medicinal products containing biotechnologically-derived proteins as active substances: quality issues (Niklas Ekman)

English (EN) (159.22 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - EGA’s perspective on the draft quality guideline (Joerg Windisch)

English (EN) (922.36 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substances: Quality issues

English (EN) (656.89 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues (Niklas Ekman)

English (EN) (309.73 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues (Hans-Karl Heim)

English (EN) (117.28 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - Guideline on Similar biological medicinal products containing biotechnology-derived proteins as active substance: Non-clinical and clinical issues (Pekka Kurki)

English (EN) (360.9 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - EBG’s perspective on the draft guideline on the non-clinical/clinical issues (Mark McCamish)

English (EN) (1.18 MB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Presentation - Nonclinical and clinical considerations

English (EN) (571.74 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Multimedia

Share this page